VLA 0.00% $1.75 viralytics limited

1 out of 1

  1. 128 Posts.
    lightbulb Created with Sketch. 3

    Wow,

    If my in-depth knowledge of all things medical gained from Accounting is any guide (quite possibly not) this sounds fantastic. The first evaluable patient has become eligible to join an extension study (that I did not know existed).

    To have reduction or stabilisation after 6 months is tremendous. One down of the 10 - 12 required. Most importantly though (if my reading is correct) this is the only pateint that can be evaluated at this stage, and it came out well.

    Have a magnificent day.

    Rgds
    KS
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.